fbpx

#type 1 diabetes

Cellaviva Sverige April 27, 2021

Pediatric diabetes study with stem cells approved

Uppsala University Hospital and the principal investigator, Professor Per-Ola Carlsson, have been granted approval from the Medical Products Agency and the Swedish Ethical Review Authority to conduct a clinical drug trial with ProTrans™ to treat children and adolescents with type-1 diabetes. The study is a phase I / II study with a total of 66 patients.

Cellaviva Sverige November 16, 2020
Stem cells in study against type 1 diabetes in children

Stem cells in study against type 1 diabetes in children

“The results of this cell therapy are very promising and it has now been shown to be effective in type 1 diabetes in a randomized, placebo-controlled study in adults. We hope to see the same positive effect in children”, says Per-Ola Carlsson, Chief Physician and Professor at Uppsala University Hospital / Uppsala University

Prepare for the summer
Prepare for the summer

Are you expecting a summer child with a due date in the holiday season?

If you are planning to order our help with the collection, make sure to order well in advance of your due date.

We, like other companies, have limited staff during the holidays. We hope you can sympathise with this!